O

Oculus Research Inc. | Raleigh, NC

Research site

(Unclaimed)

Location

4170 Fayetteville Road, Raleigh, North Carolina, United States of America

Site insights

Top conditions

Top treatments

RGN-259

Atropine

iodine

Povidone

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 5 total trials

Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

The objective of this study is to compare the safety and efficacy of RGN-259 to placebo for the treatment of Neurotrophic Keratopathy (NK)

Enrolling

Neurotrophic Keratopathy

Drug: Placebo

Drug: RGN-259

Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression

This study evaluates the progression of myopia in participants using microdosed atropine 0.01%, atropine 0.1%, or placebo ophthalmic solution. Eligib...

Enrolling

Myopia

Drug: Placebo Ophthalmic Solution

Drug: Atropine 0.01% Ophthalmic Solution

Trial sponsors

E

R

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms